KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) EBIT (2018 - 2025)

Historic EBIT for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to -$5.3 million.

  • ClearPoint Neuro's EBIT fell 228.77% to -$5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.8 million, marking a year-over-year decrease of 2107.53%. This contributed to the annual value of -$19.7 million for FY2024, which is 1202.89% up from last year.
  • Per ClearPoint Neuro's latest filing, its EBIT stood at -$5.3 million for Q3 2025, which was down 228.77% from -$5.7 million recorded in Q2 2025.
  • Over the past 5 years, ClearPoint Neuro's EBIT peaked at -$2.2 million during Q1 2021, and registered a low of -$7.1 million during Q2 2023.
  • For the 5-year period, ClearPoint Neuro's EBIT averaged around -$4.7 million, with its median value being -$4.7 million (2023).
  • Its EBIT has fluctuated over the past 5 years, first plummeted by 19917.51% in 2021, then soared by 3375.4% in 2024.
  • ClearPoint Neuro's EBIT (Quarter) stood at -$4.0 million in 2021, then decreased by 12.23% to -$4.5 million in 2022, then fell by 5.3% to -$4.7 million in 2023, then fell by 20.02% to -$5.6 million in 2024, then increased by 6.59% to -$5.3 million in 2025.
  • Its EBIT was -$5.3 million in Q3 2025, compared to -$5.7 million in Q2 2025 and -$6.2 million in Q1 2025.